Abstract: The present invention relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs. In some embodiments, methods and compositions for assessing perfusion and innervation mismatch in a portion of a subject are provided.

Abstract: A pure peanut butter is prepared by compounded peanut varieties. The raw material of the pure peanut butter includes: 50 to 90 parts of high oleic peanuts and 10 to 50 parts of high sugar peanuts. The preparation method is as follows: high oleic peanuts and high sugar peanuts are respectively baked, the baking conditions for the high oleic peanuts are as follows: a baking temperature of 140 to 180° C., and a baking time of 15 to 35 minutes; the baking conditions for the high sugar peanuts are as follows: a baking temperature of 130 to 160° C., and a baking time of 10 to 30 minutes; and the baked high oleic peanuts and high sugar peanuts are subjected to ventilation and cooling, and after removal of peanut skin, mixed and then subjected to coarse grinding and fine grinding.

Abstract: A pipeline collector is used for bundling at least one hose. The pipeline collector comprises at least one bundling member corresponding to the hoses and is characterized in that each of the bundling members comprises a bundling body, a first top edge positioned at one side of the bundling body, a second top edge defined at the other side of the bundling body relative to the first top edge, and a first accommodation area which is recessed from the surface of the bundling body relative to the hoses and penetrates through the first top edge and the second top edge, wherein a profile of the first accommodation area is non-orthogonally disposed relative to the first top edge or the second top edge.

Abstract: The present disclosure provides a composite monocrystalline film, which may comprise the following seven layers; a substrate (110); a first transition layer (115) disposed on the substrate; a first isolation layer (120) disposed on the first transition layer; a second transition layer (125) disposed on the first isolation layer; a first film layer (130) disposed on the second transition layer; a third transition layer (135) disposed on the first film layer; and a second film layer (140) disposed on the third transition layer, wherein the first transition layer, second transition layer, and third transition layer may include H and Ar.

Abstract: The invention provides a micron-scale monocrystal film. The micron-scale monocrystal film includes 1) a substrate layer, and 2) a micron-scale monocrystal film layer located on the substrate layer, wherein a transition layer is interposed between the substrate layer and micron-scale monocrystal film layer, and the transition layer may include a first transition layer disposed adjacent to the substrate layer and a second transition layer disposed adjacent to the micron monocrystal film layer, wherein the transition layer may include H and an element from at least one kind of plasma gas used during the plasma bonding of the substrate layer and the micron-scale monocrystal film layer.

Abstract: The present invention provides compounds of Formula (I). wherein A and Z are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and may be useful for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

Abstract: A method for preparing a Pickering emulsion using a peanut protein isolate includes preparing a peanut protein isolate dispersion liquid from a peanut protein isolate solution as a raw material; preparing a mixed dispersion of protein and polysaccharide using a polysaccharide solution and the peanut protein isolate dispersion; adding transglutaminase to the mixed dispersion of protein and polysaccharide, preparing a monolithic gel by cross-linking reaction; preparing a microgel particle dispersion by using the monolithic gel as a raw material; and further adding the microgel particle dispersion to an edible oil to obtain a Pickering emulsion. During the preparation process, no inorganic material is added, and the obtained Pickering emulsion has good biosafety and strong biocompatibility. The prepared Pickering emulsion can keep stable at room temperature for 30 days or more, and can be used as a delivery system for fat-soluble and photosensitive active substances.

Abstract: A method for data processing comprises: S100. if a to-be-sent email needs to be saved cryptographically or sent cryptographically, automatically converting a main body of the mail into an html file, the html file including an attachment link for linking a mail attachment; S200. compressing a filename of the html file and a filename of the mail attachment into a new html filename and a new mail attachment name using a first open source algorithm based on a first password preset between a sender and a recipient, thereby obtaining a renamed html file and a renamed mail attachment; S300. compressing the renamed html and the renamed mail attachment using a second open source algorithm based on a second password preset between the sender and the recipient, thereby obtaining a compressed file; and S400.

Abstract: The present invention provides a flavor extract of low-temperature-pressed peanut cake which is extracted from low-temperature-pressed peanut cake. In the flavor extract, the content of pyrazines flavor substances is not less than 55%, and the content of the aldehydes substances is not more than 15%. The present invention also provides a method for improving the flavor of peanut oil by using the flavor extract of the low-temperature-pressed peanut cake. The flavor extract extracted from peanut cake according to the present invention, which contains 55% or more pyrazines flavor substances, can not only improve the flavor of low-temperature-pressed peanut oil significantly, but also retain the original quality and color of the low-temperature-pressed peanut oil when it is added to low-temperature-pressed peanut oil.

Abstract: The present invention provides compounds of Formula (I): wherein the substituents are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.

Abstract: A peanut protein vegetarian sausage and a preparation method thereof are described. The peanut protein vegetarian sausage is prepared from components including low-temperature defatted peanut protein powder, soybean protein isolate, vital wheat gluten, and modifier. The vegetarian sausage has a protein content of 60% or more, zero cholesterol and low fat, and has the characteristics of good taste, being rich in nutrients and convenience to eat. Also described are a preparation method of the vegetarian sausage, which includes mixing the main materials, performing an extrusion treatment, adding water and an auxiliary material online during the extrusion, and cooling the product obtained after extrusion molding to give the peanut protein vegetarian sausage. The preparation method is a pure physical processing method with a high degree of automation, and the processing is free from any pollutant discharge.

Abstract: A key with balance rods and a keyboard are provided. The key includes a base plate. A sensing component is disposed on the base plate. An intermediate plate is disposed on the sensing component. The intermediate plate has a key hole and a receiving chamber which penetrate upper and lower surfaces of the intermediate plate. A keying portion is disposed on the base plate. Balance rods are disposed between a lower surface of the keying portion and a lower surface of the intermediate plate or base plate. Two balance rods run in the direction of X-axis or the direction of Y-axis, whereas one balance rod runs in the other direction and between the two balance rods. The three balance rods neither cross nor overlap. The key with balance rods and the keyboard have a comfortable feel and are applicable to laptops with thin keyboards, tablets, and smartphone keyboards.

Abstract: A method for preventing hijacking of a web page is provided. A HyperText Markup Language (HTML) source file is received from a web server in response to a HyperText Transfer Protocol (HTTP) access request, the HTML source file being embedded with a script tag corresponding to script code for preventing HTTP hijacking. The script code for preventing HTTP hijacking is pulled from an antihijacking server according to the script tag. It is detected, based on the script code for preventing HTTP hijacking, whether a document object model (DOM) node used for HTTP hijacking exists in a DOM tree. The DOM node used for HTTP hijacking is hidden from a web page of a browser in response to detecting that the DOM node used for HTTP hijacking.

Abstract: A permanent magnet DC (PMDC) motor, including: a motor body including a revolving shaft; a Hall sensing module; a gear reducer; and a gear assembly including an output shaft; and a magnet ring. The gear assembly is disposed in the gear reducer. The gear assembly is connected to and driven by the revolving shaft of the motor body. The magnet ring is disposed on the revolving shaft or on the output shaft of the gear assembly. The Hall sensing module is disposed on the gear reducer. The Hall sensing module is adapted to sense a signal of the magnet ring to detect the revolving speed of the revolving shaft or the output shaft, and transmit detected data with regard to the revolving speed.

Abstract: The present invention provides compounds of Formula (I): wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

Abstract: High-moisture TPP and its preparation by crushing and mixing low-temperature defatted peanut protein powder and extrusion texturizing at 60° C. to 80° C. in the feeding zone, 90° C. to 100° C. in the mixing zone, 120° C. to 160° C. in the melting zone, 90° C. to 150° C. at the cooling die, and 50° C. to 100° C. in the molding zone. Water is added online during extrusion to adjust the moisture content to 45% to 60%. The cooled product is high-moisture TPP that has a moisture content of 55% or more, bright white color, fragrant taste, abundant fibrous structure, is immediately edible, and can be used as a substitute for meat in the manufacture of chicken dices, pulled meat, vegetarian sausage and the like. The method fully utilizes raw materials, has almost no waste, is continuous, has a high process integration, and low energy consumption, and it can enhance the value of peanut protein powder.

Abstract: Compositions, e.g., therapeutic agents, and methods are provided for modulating gene and protein expression of Forkhead Box protein 1 (Foxp1). The therapeutic agents include short nucleic acid molecules that modulate gene and protein expression of Forkhead Box protein 1 (Foxp1) expression, viral vectors containing such molecules, T cells transduced with these viruses for adoptive therapies, and any small molecules that bind to and inactivate Foxp1. These compounds and methods have applications in cancer therapy either alone or in combination with other therapies that stimulate the endogenous immune system in the environment of the cancer, e.g., tumor.

Abstract: The present invention provides compounds of Formula (I): wherein the substituents are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.